Association Between Gut Microbiota Composition And Risk Of Cardiovascular Disease: A Systematic Review And Meta-Analysis
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (36s)
DOI: 10.25258/ijddt.16.36s.14 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Suguna L.
Abstract (Originalsprache)
The composition of the gut microbiota and the consequences of cardiovascular disease (CVD) appear to be strongly correlated, according to new research. The goal of this systematic literature review and meta-analysis is to summarize recent findings on the gut-heart axis, find microbial signatures linked to CVD, and assess how well microbiota-directed therapies work. A detailed review was conducted on 30 peer-reviewed papers, including observational studies, randomized controlled trials, meta-analyses, and experimental models, that were published between 2020 and 2025. Information on demographic characteristics, intervention kinds, cardiovascular outcomes, and microbiological profiling techniques was extracted. A meta-analysis of five trials evaluating the effects of therapies targeting the microbiota on inflammatory biomarkers and systolic blood pressure was conducted. All CVD subtypes showed consistent microbial dysbiosis, with pro-inflammatory species increasing and SCFA-producing taxa decreasing. Interventions that modulate the microbiota, like probiotics, omega-3 fatty acids, and dietary fiber, significantly decreased CRP levels (−1.3 mg/L; p < 0.01) and systolic blood pressure (mean difference: −5.2 mmHg; p < 0.001). Numerous studies used multi-omics techniques to find unique microbial signatures that predict cardiovascular risk, indicating the possibility of new therapeutic and diagnostic advancements. The results support the gut microbiota as a therapeutic target and a mechanistic component to cardiovascular disease. One promising strategy for improving cardiovascular health is the customization of microbiota. Standardized procedures, longitudinal designs, and precise methods that combine host and microbial data should be given top priority in future studies.
Zitieren
APA
L, S. (2026). Association Between Gut Microbiota Composition And Risk Of Cardiovascular Disease: A Systematic Review And Meta-Analysis. International Journal of Drug Delivery Technology, 16(36s). https://doi.org/10.25258/ijddt.16.36s.14
Vancouver
L S. Association Between Gut Microbiota Composition And Risk Of Cardiovascular Disease: A Systematic Review And Meta-Analysis. International Journal of Drug Delivery Technology. 2026;16(36s). doi:10.25258/ijddt.16.36s.14
BibTeX
@article{L2026,
author = {L, Suguna},
title = {Association Between Gut Microbiota Composition And Risk Of Cardiovascular Disease: A Systematic Review And Meta-Analysis},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {36s},
doi = {10.25258/ijddt.16.36s.14}
}
EUVIMED